Donald Trump’s vice-presidential pick has indicated he favors a hands-off approach to A.I. but also wants to increase scrutiny of the biggest tech firms in the field.
Category: Khan, Lina
-
F.T.C. Says Middlemen Seem to Drive Up Drug Prices
In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.
-
U.S. Clears Way for Antitrust Inquiries of Nvidia, Microsoft and OpenAI
The Justice Department and the Federal Trade Commission agreed to divide responsibility for investigating three major players in the artificial intelligence industry.
-
An Emboldened F.T.C. Bolsters Biden’s Efforts to Address Inflation
With few unilateral options and little hope of legislation from Congress, the president’s early investment in competition policy could pay a political dividend.
-
US Agencies Start Inquiry Into Generic Drug Shortages
The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
-
Lina Khan’s FTC Takes On AI Deals like Microsoft-OpenAI
The agency is concerned that transactions including Microsoft’s $13 billion investment in OpenAI could hinder competition and innovation.